{
    "nct_id": "NCT04663100",
    "official_title": "Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence",
    "inclusion_criteria": "* Receiving cancer care at Vanderbilt University Medical Center\n* Diagnosis of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), chronic myeloid leukemia (CML), or multiple myeloma (MM)\n* Initiating an oral anticancer agent, either for the first time or a change from previous oral agent\n* Diagnosis of 2 chronic conditions, including at least one of the following: diabetes, hypertension, hyperlipidemia, congestive heart failure, depression/anxiety, gastroesophageal reflux disease, and/or chronic obstructive pulmonary disease\n* Patients taking at least two chronic medications, including at least one medication for one of the conditions listed above.\n* Willing and able to sign informed consent.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Cannot communicate in English\n* Concurrent diagnosis of type 1 diabetes or human immunodeficiency virus",
    "miscellaneous_criteria": ""
}